From: Malawian children with fast-breathing pneumonia with and without comorbidities
 | ITIP3 fast-breathing pneumonia cohort | ITIP1 | |||||
---|---|---|---|---|---|---|---|
HIVb,c | Malariab,d | Severe acute malnutritionb,f | Anemiab,e | Total | 3 days placebo | 3 days amoxicillin | |
(N = 57) | (N = 20) | (N = 2) | (N = 17) | (N = 79) | (N = 562) | (N = 564) | |
Day 14 clinical outcome | |||||||
 Cured | 50 / 51 (98%) | 15 / 17 (88.2%) | 2 / 2 (100%) | 13 / 14 (92.9%) | 68 / 71 (95.8%) | 517 / 527 (98.1%) | 525 / 543 (96.7%) |
 Not cured | 1 / 51 (2%) | 2 / 17 (11.8%) | 0 / 2 (0%) | 1 / 14 (7.1%) | 3 / 71 (4.2%) | 10 / 527 (1.9%) | 18 / 543 (3.3%) |
 Unknown clinical outcome | 6 / 57 (10.5%) | 3 / 20 (15%) | 0 / 2 (0%) | 3 / 17 (17.6%) | 8 / 79 (10.1%) | 35 / 562 (6.2%) | 21 / 564 (3.7%) |
 Loss to follow-up or consent withdrawn | 3 / 57 (5.3%) | 3 / 20 (15%) | 0 / 2 (0%) | 3 / 17 (17.6%) | 5 / 79 (6.3%) | 27 / 562 (4.8%) | 18 / 564 (3.2%) |
 Missing visit | 3 / 57 (5.3%) | 0 / 20 (0%) | 0 / 2 (0%) | 0 / 17 (0%) | 3 / 79 (3.8%) | 8 / 562 (1.4%) | 3 / 564 (0.5%) |